Florida nurse practitioner convicted in $200 million Medicare fraud scheme

Florida nurse practitioner convicted in 0 million Medicare fraud scheme


Michael Nesterov | Istock | Getty Images

A federal jury in Miami convicted a Florida nurse practitioner of health-care conspiracy and other charges for playing a key role in a scheme that swindled hundreds of millions of dollars from Medicare.

Elizabeth Hernandez, 45, fraudulently billed Medicare for more than $200 million in orthotic braces and genetic tests that were medically unnecessary, according to the Department of Justice.

Medicare is the federal program that provides health coverage to primarily older Americans.

Hernandez, who was found guilty Thursday by jurors after a trial that lasted several days, participated in a broad scheme in which telemarketing companies would contact Medicare patients to persuade them to request unnecessary braces and tests, the DOJ said.

CNBC Politics

Read more of CNBC’s politics coverage:

These companies then sent pre-filled orders to Hernandez, who signed them, attesting that she had examined or treated the patients although she had never spoken with many of them, prosecutors said.

Hernandez routinely billed Medicare for more than 24 hours of purported “office visits” in a single day, the DOJ said.

And, “In 2020, Hernandez ordered more cancer genetic tests for Medicare beneficiaries than any other provider in the nation, including oncologists and geneticists,” the department said.

She personally pocketed $1.6 million in stolen money which she used to buy pricey cars, jewelry, home renovations and trips, the prosecutors said.

Hernandez is scheduled to be sentenced Dec. 14. She faces a maximum possible sentence of 20 years in prison on the top count of conspiracy to commit health care fraud, with lesser maximums for health care fraud and making false statements.

A lawyer for Hernandez did not immediately respond to a request for comment.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More